Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

460 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
RE: Drug risk assessment and data reuse.
Toh S, Avorn J, D'Agostino RB Sr, Gurwitz JH, Psaty BM, Rothman KJ, Saag KG, Sturkenboom MC, Vandenbroucke JP, Winterstein AG, Strom BL. Toh S, et al. Among authors: saag kg. Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):109-10. doi: 10.1002/pds.3525. Pharmacoepidemiol Drug Saf. 2014. PMID: 24395550 No abstract available.
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems.
Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Nourjah P, Saag KG. Herrinton LJ, et al. Among authors: saag kg. Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1199-209. doi: 10.1002/pds.2196. Epub 2011 Sep 15. Pharmacoepidemiol Drug Saf. 2011. PMID: 21919113 Free PMC article.
Association between anti-TNF-α therapy and interstitial lung disease.
Herrinton LJ, Harrold LR, Liu L, Raebel MA, Taharka A, Winthrop KL, Solomon DH, Curtis JR, Lewis JD, Saag KG. Herrinton LJ, et al. Among authors: saag kg. Pharmacoepidemiol Drug Saf. 2013 Apr;22(4):394-402. doi: 10.1002/pds.3409. Epub 2013 Jan 29. Pharmacoepidemiol Drug Saf. 2013. PMID: 23359391 Free PMC article.
How to ascertain drug safety in the context of benefit. Controversies and concerns.
Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, Saag KG, Silman AJ, Stevens R, Tyndall A. Simon LS, et al. Among authors: saag kg. J Rheumatol. 2009 Sep;36(9):2114-21. doi: 10.3899/jrheum.090591. J Rheumatol. 2009. PMID: 19738223
460 results